The primary aim of this study was to analyse plasma and urinary CCL20 levels in human CKD caused by diabetes or ADPKD, representing examples of kidney disease in response to systemic events and of a primary non-immune kidney disease, respectively. This evidence concerns the gene CCL20 and diabetes mellitus.